HEPARIN PREVENTS FORMATION OF THE HUMAN C-3 AMPLIFICATION CONVERTASE BY INHIBITING THE BINDING-SITE FOR B ON C3B

被引：49

作者：

MAILLET, F ^{[1
]}

KAZATCHKINE, MD ^{[1
]}

GLOTZ, D ^{[1
]}

FISCHER, E ^{[1
]}

ROWE, M ^{[1
]}

机构：

[1] HOP BROUSSAIS,DEPT NEPHROL,INSERM,U28,F-75674 PARIS 14,FRANCE

来源：

MOLECULAR IMMUNOLOGY | 1983年 / 20卷 / 12期

关键词：

D O I：

10.1016/0161-5890(83)90172-4

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1401 / 1404

页数：4

共 19 条

[1]

BAKER PJ, 1975, J IMMUNOL, V114, P554

[2]

DAHA MR, 1976, IMMUNOLOGY, V31, P789

[3] Anticomplementary power of heparin [J].

Ecker, EE ;

Gross, P .

JOURNAL OF INFECTIOUS DISEASES, 1929, 44 :250-253

[4] PROPERDIN - BINDING TO C3B AND STABILIZATION OF C3B-DEPENDENT C3 CONVERTASE [J].

FEARON, DT ;

AUSTEN, KF .

JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (04) :856-863

[5] ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS [J].

FEARON, DT ;

AUSTEN, KF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (04) :1683-1687

[6]

HUNSICKE.LG, 1973, J IMMUNOL, V110, P128

[7] SURFACE-ASSOCIATED HEPARIN INHIBITS ZYMOSAN-INDUCED ACTIVATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY BY AUGMENTING THE REGULATORY ACTION OF THE CONTROL PROTEINS ON PARTICLE-BOUND C3B [J].

KAZATCHKINE, MD ;

FEARON, DT ;

SILBERT, JE ;

AUSTEN, KF .

JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (05) :1202-1215

[8]

KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75

[9] STRUCTURAL DETERMINANTS OF THE CAPACITY OF HEPARIN TO INHIBIT THE FORMATION OF THE HUMAN AMPLIFICATION C3-CONVERTASE [J].

KAZATCHKINE, MD ;

FEARON, DT ;

METCALFE, DD ;

ROSENBERG, RD ;

AUSTEN, KF .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (01) :223-228

[10] MODE OF INTERACTION OF DIFFERENT POLYANIONS WITH 1ST (C1, C1BAR), 2ND (C2) AND 4TH (C4) COMPONENT OF COMPLEMENT .2. EFFECT OF POLYANIONS ON BINDING OF C2 TO EAC4B [J].

LOOS, M ;

VOLANAKIS, JE ;

STROUD, RM .

IMMUNOCHEMISTRY, 1976, 13 (03) :257-261

← 1 2 →